Standard
Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry. / Glintborg, Bente; Jensen, Dorte Vendelbo; Engel, Sara; Terslev, Lene; Pfeiffer Jensen, Mogens; Hendricks, Oliver; Østergaard, Mikkel; Horskjær Rasmussen, Simon; Adelsten, Thomas; Colic, Ada; Danebod, Kamilla; Kildemand, Malene; Loft, Anne Gitte; Munk, Heidi Lausten; Pedersen, Jens Kristian; Østgård, René Drage; Møller Sørensen, Christian; Krogh, Niels Steen; Nørgaard Agerbo, Jette; Ziegler, Connie; Lund Hetland, Merete.
I:
RMD Open, Bind 7, Nr. 2, e001649, 2021.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Glintborg, B, Jensen, DV, Engel, S
, Terslev, L, Pfeiffer Jensen, M, Hendricks, O
, Østergaard, M, Horskjær Rasmussen, S, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, AG, Munk, HL, Pedersen, JK, Østgård, RD, Møller Sørensen, C, Krogh, NS, Nørgaard Agerbo, J, Ziegler, C
& Lund Hetland, M 2021, '
Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry',
RMD Open, bind 7, nr. 2, e001649.
https://doi.org/10.1136/rmdopen-2021-001649
APA
Glintborg, B., Jensen, D. V., Engel, S.
, Terslev, L., Pfeiffer Jensen, M., Hendricks, O.
, Østergaard, M., Horskjær Rasmussen, S., Adelsten, T., Colic, A., Danebod, K., Kildemand, M., Loft, A. G., Munk, H. L., Pedersen, J. K., Østgård, R. D., Møller Sørensen, C., Krogh, N. S., Nørgaard Agerbo, J.
, ... Lund Hetland, M. (2021).
Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry.
RMD Open,
7(2), [e001649].
https://doi.org/10.1136/rmdopen-2021-001649
Vancouver
Glintborg B, Jensen DV, Engel S
, Terslev L, Pfeiffer Jensen M, Hendricks O o.a.
Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry.
RMD Open. 2021;7(2). e001649.
https://doi.org/10.1136/rmdopen-2021-001649
Author
Glintborg, Bente ; Jensen, Dorte Vendelbo ; Engel, Sara ; Terslev, Lene ; Pfeiffer Jensen, Mogens ; Hendricks, Oliver ; Østergaard, Mikkel ; Horskjær Rasmussen, Simon ; Adelsten, Thomas ; Colic, Ada ; Danebod, Kamilla ; Kildemand, Malene ; Loft, Anne Gitte ; Munk, Heidi Lausten ; Pedersen, Jens Kristian ; Østgård, René Drage ; Møller Sørensen, Christian ; Krogh, Niels Steen ; Nørgaard Agerbo, Jette ; Ziegler, Connie ; Lund Hetland, Merete. / Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry. I: RMD Open. 2021 ; Bind 7, Nr. 2.
Bibtex
@article{4a56b6de7e3c43a18fa3e83dcf434b8a,
title = "Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry",
keywords = "arthritis, COVID-19, patient reported outcome measures",
author = "Bente Glintborg and Jensen, {Dorte Vendelbo} and Sara Engel and Lene Terslev and {Pfeiffer Jensen}, Mogens and Oliver Hendricks and Mikkel {\O}stergaard and {Horskj{\ae}r Rasmussen}, Simon and Thomas Adelsten and Ada Colic and Kamilla Danebod and Malene Kildemand and Loft, {Anne Gitte} and Munk, {Heidi Lausten} and Pedersen, {Jens Kristian} and {\O}stg{\aa}rd, {Ren{\'e} Drage} and {M{\o}ller S{\o}rensen}, Christian and Krogh, {Niels Steen} and {N{\o}rgaard Agerbo}, Jette and Connie Ziegler and {Lund Hetland}, Merete",
note = "Funding Information: Funding This study was partly funded by an unrestricted grant from The Lundbeck Foundation (grant number R349-2020-629). Funding Information: Competing interests BG: Research grants: AbbVie, BMS, Pfizer. OH: Research grants: AbbVie, Novartis, Pfizer. LT: Speakers fee: Speakers fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS and GE. MO: Research grants: Abbvie, BMS, Celgene, Merck, Novartis; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. RDO: Research grants: Abbvie; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi and UCB. AGL: Consultancy and/or speakers fees: AbbVie, Eli-Lilly, Janssen, MSD, Novartis, Pfizer and UCB. MLH: AbbVie, Biogen, BMS, Celtrion, Eli Lilly Denmark A/S, Janssen Biologics B.V, Lundbeck Fonden, MSD, Pfizer, Roche, Samsung Biopis, Sandoz. MLH chairs the steering committee of the Danish Rheumatology Quality Registry (DANBIO), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs the EuroSpA research collaboration, which generates real-world evidence of treatment of psoriatic arthritis and axial spondylorthritis based on secondary data and is partly funded by Novartis.",
year = "2021",
doi = "10.1136/rmdopen-2021-001649",
language = "English",
volume = "7",
journal = "RMD Open",
issn = "2056-5933",
publisher = "BMJ Publishing Group",
number = "2",
}
RIS
TY - JOUR
T1 - Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry
AU - Glintborg, Bente
AU - Jensen, Dorte Vendelbo
AU - Engel, Sara
AU - Terslev, Lene
AU - Pfeiffer Jensen, Mogens
AU - Hendricks, Oliver
AU - Østergaard, Mikkel
AU - Horskjær Rasmussen, Simon
AU - Adelsten, Thomas
AU - Colic, Ada
AU - Danebod, Kamilla
AU - Kildemand, Malene
AU - Loft, Anne Gitte
AU - Munk, Heidi Lausten
AU - Pedersen, Jens Kristian
AU - Østgård, René Drage
AU - Møller Sørensen, Christian
AU - Krogh, Niels Steen
AU - Nørgaard Agerbo, Jette
AU - Ziegler, Connie
AU - Lund Hetland, Merete
N1 - Funding Information:
Funding This study was partly funded by an unrestricted grant from The Lundbeck Foundation (grant number R349-2020-629).
Funding Information:
Competing interests BG: Research grants: AbbVie, BMS, Pfizer. OH: Research grants: AbbVie, Novartis, Pfizer. LT: Speakers fee: Speakers fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS and GE. MO: Research grants: Abbvie, BMS, Celgene, Merck, Novartis; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. RDO: Research grants: Abbvie; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi and UCB. AGL: Consultancy and/or speakers fees: AbbVie, Eli-Lilly, Janssen, MSD, Novartis, Pfizer and UCB. MLH: AbbVie, Biogen, BMS, Celtrion, Eli Lilly Denmark A/S, Janssen Biologics B.V, Lundbeck Fonden, MSD, Pfizer, Roche, Samsung Biopis, Sandoz. MLH chairs the steering committee of the Danish Rheumatology Quality Registry (DANBIO), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs the EuroSpA research collaboration, which generates real-world evidence of treatment of psoriatic arthritis and axial spondylorthritis based on secondary data and is partly funded by Novartis.
PY - 2021
Y1 - 2021
KW - arthritis
KW - COVID-19
KW - patient reported outcome measures
U2 - 10.1136/rmdopen-2021-001649
DO - 10.1136/rmdopen-2021-001649
M3 - Journal article
C2 - 33941664
AN - SCOPUS:85105248472
VL - 7
JO - RMD Open
JF - RMD Open
SN - 2056-5933
IS - 2
M1 - e001649
ER -
